Ponoi Management, LLC - Insider Trading Tracker

न्यूरिक्स थेरेप्यूटिक्स, इंक.

US ˙ NasdaqGM ˙ US67080M1036

परिचय

यह पृष्ठ Ponoi Management, LLC के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Ponoi Management, LLC ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:RAPT / RAPT Therapeutics, Inc.	10% Owner	0
US:NGM / NGM Biopharmaceuticals, Inc.	10% Owner	1,000
US:NRIX / Nurix Therapeutics, Inc.	10% Owner	48,406
	10% Owner	99,155
US:RVMD / Revolution Medicines, Inc.	10% Owner	2,429,180
US:IMDZ / Immune Design Corp.	10% Owner	0
US:RCUS / Arcus Biosciences, Inc.	10% Owner	0

चार्ट को कैसे समझे

निम्नलिखित चार्ट Ponoi Management, LLC द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी NRIX / Nurix Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम NRIX / Nurix Therapeutics, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

NRIX / Nurix Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री NRIX / Nurix Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम NRIX / Nurix Therapeutics, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RAPT / RAPT Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2022-05-24	RAPT	COLUMN GROUP II, LP	15,776	12.0021	1,972	96.0168	189,345	283	30.8000	-128,607	-67.92
2022-05-24	RAPT	COLUMN GROUP II, LP	538	12.0021	67	96.0168	6,457
2022-05-23	RAPT	COLUMN GROUP II, LP	9,898	12.4993	1,237	99.9944	123,718
2022-05-23	RAPT	COLUMN GROUP II, LP	338	12.4993	42	99.9944	4,225
2019-11-04	RAPT	COLUMN GROUP II, LP	625,000	12.0000	78,125	96.0000	7,500,000

RAPT / RAPT Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री RAPT / RAPT Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-09-27	RAPT	COLUMN GROUP II, LP	7,500	34.4808	938	275.8464	258,606	224	10.2600	-248,992	-96.28
2021-09-27	RAPT	COLUMN GROUP II, LP	1,114	34.9650	139	279.7200	38,951
2021-09-27	RAPT	COLUMN GROUP II, LP	625	34.9446	78	279.5568	21,840
2021-09-15	RAPT	COLUMN GROUP II, LP	11,476	37.2138	1,434	297.7104	427,066
2021-09-15	RAPT	COLUMN GROUP II, LP	4,400	37.6732	550	301.3856	165,762
2021-09-15	RAPT	COLUMN GROUP II, LP	12,939	37.2234	1,617	297.7872	481,634
2021-09-15	RAPT	COLUMN GROUP II, LP	4,720	37.7028	590	301.6224	177,957
2021-09-14	RAPT	COLUMN GROUP II, LP	1,400	35.7071	175	285.6568	49,990
2021-09-14	RAPT	COLUMN GROUP II, LP	29,634	36.7869	3,704	294.2952	1,090,143
2021-09-14	RAPT	COLUMN GROUP II, LP	25,351	37.2705	3,169	298.1640	944,844
2021-09-14	RAPT	COLUMN GROUP II, LP	1,700	35.7732	212	286.1856	60,814
2021-09-14	RAPT	COLUMN GROUP II, LP	42,151	36.9160	5,269	295.3280	1,556,046
2021-09-14	RAPT	COLUMN GROUP II, LP	10,807	37.3148	1,351	298.5184	403,261
2021-09-14	RAPT	COLUMN GROUP II, LP	1,496	35.7466	187	285.9728	53,477
2021-09-14	RAPT	COLUMN GROUP II, LP	32,211	36.8528	4,026	294.8224	1,187,066
2021-09-14	RAPT	COLUMN GROUP II, LP	2,926	37.3062	366	298.4496	109,158
2021-09-13	RAPT	COLUMN GROUP II, LP	4,803	35.2506	600	282.0048	169,309
2021-09-13	RAPT	COLUMN GROUP II, LP	4,726	35.2713	591	282.1704	166,692
2021-09-13	RAPT	COLUMN GROUP II, LP	4,788	35.2845	598	282.2760	168,942
2021-09-10	RAPT	COLUMN GROUP II, LP	7,187	35.1941	898	281.5528	252,940
2021-09-10	RAPT	COLUMN GROUP II, LP	7,320	35.1875	915	281.5000	257,572
2021-09-10	RAPT	COLUMN GROUP II, LP	7,231	35.1949	904	281.5592	254,494
2021-09-02	RAPT	COLUMN GROUP II, LP	18,545	35.4318	2,318	283.4544	657,083
2021-09-02	RAPT	COLUMN GROUP II, LP	18,556	35.4316	2,320	283.4528	657,469
2021-09-01	RAPT	COLUMN GROUP II, LP	6,904	35.0163	863	280.1304	241,753
2021-09-01	RAPT	COLUMN GROUP II, LP	8,976	35.3915	1,122	283.1320	317,674
2021-09-01	RAPT	COLUMN GROUP II, LP	8,805	35.0575	1,101	280.4600	308,681
2021-09-01	RAPT	COLUMN GROUP II, LP	7,064	35.4592	883	283.6736	250,484
2021-08-24	RAPT	COLUMN GROUP II, LP	2,300	30.8057	288	246.4456	70,853
2021-08-24	RAPT	COLUMN GROUP II, LP	3,486	31.7575	436	254.0600	110,707
2021-08-24	RAPT	COLUMN GROUP II, LP	2,200	30.7909	275	246.3272	67,740
2021-08-24	RAPT	COLUMN GROUP II, LP	3,463	31.7581	433	254.0648	109,978
2021-08-24	RAPT	COLUMN GROUP II, LP	4,318	30.9408	540	247.5264	133,602
2021-08-24	RAPT	COLUMN GROUP II, LP	7,100	31.7651	888	254.1208	225,532
2021-08-23	RAPT	COLUMN GROUP II, LP	7,605	30.9267	951	247.4136	235,198
2021-08-23	RAPT	COLUMN GROUP II, LP	12,969	31.4113	1,621	251.2904	407,373
2021-08-23	RAPT	COLUMN GROUP II, LP	2,200	32.3490	275	258.7920	71,168
2021-08-23	RAPT	COLUMN GROUP II, LP	7,278	30.9187	910	247.3496	225,026
2021-08-23	RAPT	COLUMN GROUP II, LP	13,623	31.4035	1,703	251.2280	427,810
2021-08-23	RAPT	COLUMN GROUP II, LP	2,007	32.3926	251	259.1408	65,012
2021-08-23	RAPT	COLUMN GROUP II, LP	8,204	30.9429	1,026	247.5432	253,856
2021-08-23	RAPT	COLUMN GROUP II, LP	12,354	31.4168	1,544	251.3344	388,123
2021-08-23	RAPT	COLUMN GROUP II, LP	2,100	32.3831	262	259.0648	68,005
2021-08-20	RAPT	COLUMN GROUP II, LP	1,440	30.0879	180	240.7032	43,327
2021-08-20	RAPT	COLUMN GROUP II, LP	1,429	30.0802	179	240.6416	42,985
2021-08-20	RAPT	COLUMN GROUP II, LP	1,670	30.0732	209	240.5856	50,222
2020-09-22	RAPT	COLUMN GROUP II, LP	608,000	30.8500	76,000	246.8000	18,756,800
2020-08-17	RAPT	COLUMN GROUP II, LP	538,654	22.7500	67,332	182.0000	12,254,378

इनसाइडर खरीदारी RCUS / Arcus Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

RCUS / Arcus Biosciences, Inc. Insider Trades

इनसाइडर बिक्री RCUS / Arcus Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RVMD / Revolution Medicines, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

RVMD / Revolution Medicines, Inc. Insider Trades

इनसाइडर बिक्री RVMD / Revolution Medicines, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-11-16	RVMD	COLUMN GROUP III, LP	952,023	36.4000	952,023	36.4000	34,653,637	269	23.95	-11,852,686	-34.20
2020-11-16	RVMD	COLUMN GROUP III, LP	1,075,133	36.4000	1,075,133	36.4000	39,134,841

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Ponoi Management, LLC द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2024-12-23	2024-12-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	-1,599,417	0	-100.00
2024-12-23	2024-12-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	-1,352,008	50,000	-96.43
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	J - Other	1,000	1,000
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-44,000	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-15,000	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-100,000	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-100,000	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-1,298,908	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-1,298,908	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-2,265,758	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-968,990	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-858,035	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-11,103,333	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-90,442	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-2,650,177	0	-100.00
2024-04-08	2024-04-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	D - Sale to Issuer	-949,862	0	-100.00
2023-11-17	2023-11-16	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	5,840	949,862	0.62	0.62	3,627	589,959
2023-11-17	2023-11-15	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	16,791	944,022	1.81	0.71	11,880	667,896
2023-02-01	2023-01-31	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	176,730	927,231	23.55	5.00	883,403	4,634,857
2023-02-01	2023-01-30	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	7,542	750,501	1.02	5.00	37,707	3,752,205
2023-01-25	2023-01-23	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	9,900	742,959	1.35	5.00	49,494	3,714,349
2023-01-23	2023-01-20	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	500	733,059	0.07	5.00	2,498	3,662,363
2023-01-23	2023-01-19	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	37,639	732,559	5.42	5.00	188,105	3,661,037
2023-01-17	2023-01-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	5,378	694,920	0.78	4.95	26,603	3,437,491
2023-01-12	2023-01-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	209,000	689,542	43.49	4.76	994,840	3,282,220
2023-01-12	2023-01-10	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	100,070	480,542	26.30	4.84	484,519	2,326,688
2022-12-14	2022-12-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	300	380,472	0.08	4.98	1,493	1,893,495
2022-11-23	2022-11-22	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	4,330	380,172	1.15	5.00	21,646	1,900,518
2022-11-23	2022-11-21	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	35,997	375,842	10.59	5.00	179,942	1,878,759
2022-11-07	2022-11-04	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	35,058	339,845	11.50	4.72	165,320	1,602,573
2022-11-07	2022-11-03	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	104,090	304,787	51.86	4.99	519,107	1,520,003
2022-10-31	2022-10-27	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	76,877	200,697	62.09	4.86	373,638	975,428
2022-10-27	2022-10-26	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	72,774	123,820	142.57	4.85	353,041	600,676
2022-10-27	2022-10-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	51,046	51,046		4.75	242,387	242,387
2022-06-13	2022-06-09	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	32,477	90,442	56.03	13.50	438,440	1,220,967
2022-06-13	2022-06-09	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	951,684	2,650,177	56.03	13.50	12,847,734	35,777,390
2022-06-06	2022-06-02	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	1,129	57,965	1.99	13.03	14,715	755,475
2022-06-06	2022-06-02	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	33,071	1,698,493	1.99	13.03	431,024	22,136,969
2022-06-02	2022-06-01	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	3,036	56,836	5.64	13.45	40,834	764,444
2022-06-02	2022-06-01	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	88,964	1,665,422	5.64	13.45	1,196,566	22,399,926
2022-06-02	2022-05-31	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,040	53,800	3.94	13.47	27,470	724,460
2022-06-02	2022-05-31	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	59,766	1,576,458	3.94	13.47	804,797	21,228,268
2022-05-31	2022-05-27	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	89	51,760	0.17	13.45	1,197	696,239
2022-05-31	2022-05-27	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,621	1,516,692	0.17	13.45	35,256	20,401,479
2022-05-31	2022-05-26	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	667	51,671	1.31	13.49	9,000	697,223
2022-05-31	2022-05-26	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	19,534	1,514,071	1.31	13.49	263,582	20,430,117
2022-05-27	2022-05-25	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	63	42,189	0.15	12.45	785	525,460
2022-05-27	2022-05-25	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	1,837	1,236,261	0.15	12.45	22,880	15,397,507
2022-05-26	2022-05-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	1,429	51,004	2.88	13.43	19,198	685,234
2022-05-26	2022-05-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	41,863	1,494,537	2.88	13.43	562,425	20,078,955
2022-05-26	2022-05-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	588	49,575	1.20	13.37	7,860	662,719
2022-05-26	2022-05-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	17,240	1,452,674	1.20	13.37	230,464	19,419,346
2022-05-25	2022-05-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	538	42,126	1.29	12.00	6,457	505,600
2022-05-25	2022-05-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	15,776	1,234,424	1.29	12.00	189,345	14,815,680
2022-05-25	2022-05-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	338	41,588	0.82	12.50	4,225	519,821
2022-05-25	2022-05-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	9,898	1,218,648	0.82	12.50	123,718	15,232,247
2022-05-23	2022-05-20	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	628	48,987	1.30	13.48	8,464	660,227
2022-05-23	2022-05-20	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	18,406	1,435,434	1.30	13.48	248,069	19,346,205
2022-05-23	2022-05-19	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	682	48,359	1.43	13.25	9,040	640,984
2022-05-23	2022-05-19	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	19,984	1,417,028	1.43	13.25	264,882	18,782,281
2022-05-19	2022-05-18	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,067	47,677	4.53	13.20	27,292	629,522
2022-05-19	2022-05-18	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	60,583	1,397,044	4.53	13.20	799,932	18,446,429
2022-05-19	2022-05-17	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,939	45,610	6.89	13.42	39,433	611,954
2022-05-19	2022-05-17	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	86,110	1,336,461	6.89	13.42	1,155,346	17,931,431
2022-05-17	2022-05-16	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	1,094	42,671	2.63	12.90	14,114	550,520
2022-05-17	2022-05-16	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	32,072	1,250,351	2.63	12.90	413,777	16,131,403
2022-05-17	2022-05-13	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	4,269	41,577	11.44
2022-05-17	2022-05-13	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	125,096	1,218,279	11.44
2022-05-13	2022-05-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	17	37,308	0.05	11.81	201	440,447
2022-05-13	2022-05-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	485	1,093,183	0.04	11.81	5,726	12,905,791
2022-05-13	2022-05-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,728	37,291	7.89	11.62	31,702	433,362
2022-05-13	2022-05-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	79,945	1,092,698	7.89	11.62	929,049	12,698,353
2022-05-13	2022-05-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	88	34,563	0.26	11.85	1,043	409,478
2022-05-13	2022-05-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,564	1,012,753	0.25	11.85	30,376	11,998,389
2022-05-13	2022-05-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,657	34,475	8.35	11.23	29,827	387,009
2022-05-13	2022-05-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	77,866	1,010,189	8.35	11.23	874,108	11,340,180
2022-05-12	2022-05-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	41,250	41,250		10.67	440,199	440,199
2022-05-12	2022-05-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	1,208,750	1,208,750		10.67	12,899,176	12,899,176
2022-05-11	2022-05-10	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	1,032	31,818	3.35	11.36	11,727	361,567
2022-05-11	2022-05-10	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	30,233	932,323	3.35	11.36	343,556	10,594,546
2022-05-11	2022-05-09	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,745	30,786	9.79	10.79	29,627	332,270
2022-05-11	2022-05-09	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	80,430	902,090	9.79	10.79	868,073	9,736,167
2022-01-26	2022-01-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	19,791	28,041	239.89
2022-01-26	2022-01-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	579,910	821,660	239.88
2022-01-26	2022-01-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	8,250	8,250
2022-01-26	2022-01-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	241,750	241,750
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Stock Option (Right to Buy)	M - Exercise	-625	6,875	-8.33
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Stock Option (Right to Buy)	M - Exercise	-1,114	1,115	-49.98
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Stock Option (Right to Buy)	M - Exercise	-7,500	15,000	-33.33
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-625	0	-100.00	34.94	-21,840
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Common Stock	M - Exercise	625	625		19.30	12,062	12,062
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,114	0	-100.00	34.96	-38,951
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Common Stock	M - Exercise	1,114	1,114		22.20	24,731	24,731
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,500	0	-100.00	34.48	-258,606
2021-09-29	2021-09-27	4	RAPT	RAPT Therapeutics, Inc. Common Stock	M - Exercise	7,500	7,500		28.27	212,025	212,025
2021-09-16	2021-09-15	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-4,720	0	-100.00	37.70	-177,957
2021-09-16	2021-09-15	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-12,939	4,720	-73.27	37.22	-481,634	175,694
2021-09-16	2021-09-15	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-4,400	0	-100.00	37.67	-165,762
2021-09-16	2021-09-15	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-11,476	4,400	-72.29	37.21	-427,066	163,741
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-2,926	0	-100.00	37.31	-109,158
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-32,211	2,926	-91.67	36.85	-1,187,066	107,831
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,496	35,137	-4.08	35.75	-53,477	1,256,028
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-10,807	17,659	-37.96	37.31	-403,261	658,942
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-42,151	28,466	-59.69	36.92	-1,556,046	1,050,851
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,700	70,617	-2.35	35.77	-60,814	2,526,196
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-25,351	15,876	-61.49	37.27	-944,844	591,706
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-29,634	41,227	-41.82	36.79	-1,090,143	1,516,614
2021-09-16	2021-09-14	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,400	70,861	-1.94	35.71	-49,990	2,530,241
2021-09-14	2021-09-13	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-4,788	36,633	-11.56	35.28	-168,942	1,292,577
2021-09-14	2021-09-13	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-4,726	72,261	-6.14	35.27	-166,692	2,548,739
2021-09-14	2021-09-13	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-4,803	72,317	-6.23	35.25	-169,309	2,549,218
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,231	41,421	-14.86	35.19	-254,494	1,457,808
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,320	76,987	-8.68	35.19	-257,572	2,708,980
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,187	77,120	-8.52	35.19	-252,940	2,714,169
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	48,652	48,652
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	84,307	84,307
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	84,307	84,307
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	72	163	79.12
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	-279,710	0	-100.00
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	279,710	279,710
2021-09-14	2021-09-10	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	-1,166,666	1,402,008	-45.42
2021-09-03	2021-09-02	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-18,556	0	-100.00	35.43	-657,469
2021-09-03	2021-09-02	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-18,545	0	-100.00	35.43	-657,083
2021-09-03	2021-09-01	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,064	18,556	-27.57	35.46	-250,484	657,981
2021-09-03	2021-09-01	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-8,805	25,620	-25.58	35.06	-308,681	898,173
2021-09-03	2021-09-01	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-8,976	18,545	-32.62	35.39	-317,674	656,335
2021-09-03	2021-09-01	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-6,904	27,521	-20.06	35.02	-241,753	963,684
2021-08-24	2021-08-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,100	0	-100.00	31.77	-225,532
2021-08-24	2021-08-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-4,318	7,100	-37.82	30.94	-133,602	219,680
2021-08-24	2021-08-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-3,463	34,425	-9.14	31.76	-109,978	1,093,273
2021-08-24	2021-08-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-2,200	37,888	-5.49	30.79	-67,740	1,166,606
2021-08-24	2021-08-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-3,486	34,425	-9.20	31.76	-110,707	1,093,252
2021-08-24	2021-08-24	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-2,300	37,911	-5.72	30.81	-70,853	1,167,875
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-2,100	11,418	-15.53	32.38	-68,005	369,750
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-12,354	13,518	-47.75	31.42	-388,123	424,692
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-8,204	25,872	-24.08	30.94	-253,856	800,555
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-2,007	40,088	-4.77	32.39	-65,012	1,298,555
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-13,623	42,095	-24.45	31.40	-427,810	1,321,930
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,278	55,718	-11.55	30.92	-225,026	1,722,728
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-2,200	40,211	-5.19	32.35	-71,168	1,300,786
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-12,969	42,411	-23.42	31.41	-407,373	1,332,185
2021-08-24	2021-08-23	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-7,605	55,380	-12.07	30.93	-235,198	1,712,721
2021-08-24	2021-08-20	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,670	34,076	-4.67	30.07	-50,222	1,024,774
2021-08-24	2021-08-20	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,429	62,996	-2.22	30.08	-42,985	1,894,932
2021-08-24	2021-08-20	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-1,440	62,985	-2.24	30.09	-43,327	1,895,086
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	35,746	35,746
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	64,425	64,425
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	64,425	64,425
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	91	91
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	-208,403	0	-100.00
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	208,403	208,403
2021-08-20	2021-08-18	4	RAPT	RAPT Therapeutics, Inc. Common Stock	J - Other	-1,317,005	2,568,674	-33.89
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	7,752	48,406	19.07
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	17,829	139,383	14.67
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	17,829	139,383	14.67
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	-49,689	0	-100.00
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	49,689	49,689
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	-1,000,000	989,000	-50.28
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	30,347	40,654	294.43
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	111,247	121,554	1,079.33
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	105,874	116,181	1,027.20
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	-438,338	0	-100.00
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	10,307	10,307
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	10,307	10,307
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	10,307	10,307
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	438,338	438,338
2021-05-07	2021-05-05	4	NRIX	Nurix Therapeutics, Inc. Common Stock	J - Other	-2,000,000	1,394,333	-58.92
2021-02-19	2021-02-17	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	S - Sale	-10,000	99,155	-9.16	36.95	-369,503	3,663,807
2020-12-16	2020-12-14	4	CNST	CONSTELLATION PHARMACEUTICALS INC Warrant (right to buy)	X - Other	-30,107	0	-100.00
2020-12-16	2020-12-14	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	X - Other	30,107	2,584,957	1.18	1.55	46,666	4,006,683
2020-11-18	2020-11-16	4	RVMD	Revolution Medicines, Inc. Common Stock	S - Sale	-1,075,133	2,429,180	-30.68	36.40	-39,134,841	88,422,152
2020-11-18	2020-11-16	4	RVMD	Revolution Medicines, Inc. Common Stock	S - Sale	-952,023	2,151,026	-30.68	36.40	-34,653,637	78,297,346
2020-09-23	2020-09-22	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-608,000	3,835,679	-13.68	30.85	-18,756,800	118,330,697
2020-09-03	2020-09-02	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	27,595	1,827,025	1.53	17.67	487,604	32,283,532
2020-09-03	2020-09-01	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	36,494	1,799,430	2.07	17.64	643,754	31,741,945
2020-08-31	2020-08-28	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	26,135	1,762,936	1.50	17.89	467,555	31,538,925
2020-08-31	2020-08-27	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	36,359	1,736,801	2.14	17.79	646,827	30,897,690
2020-08-25	2020-08-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	100	1,700,442	0.01	18.00	1,800	30,607,956
2020-08-25	2020-08-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	11,024	1,700,342	0.65	17.96	197,991	30,538,142
2020-08-25	2020-08-21	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	7,321	1,689,318	0.44	17.97	131,558	30,357,044
2020-08-19	2020-08-17	4	RAPT	RAPT Therapeutics, Inc. Common Stock	S - Sale	-538,654	4,443,679	-10.81	22.75	-12,254,378	101,093,697
2020-08-17	2020-08-17	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	6,425	1,681,997	0.38	17.89	114,943	30,090,926
2020-08-17	2020-08-14	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	37,993	1,675,572	2.32	17.49	664,498	29,305,754
2020-08-17	2020-08-13	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	19,895	1,637,579	1.23	17.89	355,922	29,296,288
2020-08-03	2020-07-30	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	732	1,617,684	0.05	17.99	13,169	29,102,135
2020-07-30	2020-07-28	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	4,105	1,616,952	0.25	17.99	73,849	29,088,966
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Series D Preferred Stock	C - Conversion	-686,274	0	-100.00
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Series D Preferred Stock	C - Conversion	-686,274	0	-100.00
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Series B Preferred Stock	C - Conversion	-1,989,000	0	-100.00
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Series B Preferred Stock	C - Conversion	-1,836,000	0	-100.00
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Series A-2 Preferred Stock	C - Conversion	-875,000	0	-100.00
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Series A-1 Preferred Stock	C - Conversion	-600,000	0	-100.00
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Common Stock	C - Conversion	686,274	686,274
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Common Stock	C - Conversion	686,274	686,274
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Common Stock	C - Conversion	1,989,000	1,989,000
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Common Stock	C - Conversion	1,836,000	3,394,333	117.82
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Common Stock	C - Conversion	875,000	1,558,333	128.05
2020-07-29	2020-07-28	4	NRIX	Nurix Therapeutics, Inc. Common Stock	C - Conversion	600,000	683,333	720.00
2020-07-28	2020-07-27	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	3,834	1,612,847	0.24	17.99	68,974	29,015,118
2020-07-28	2020-07-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	68,749	1,609,013	4.46	17.93	1,232,670	28,849,603
2020-07-23	2020-07-22	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	193	1,540,264	0.01	18.00	3,474	27,724,752
2020-07-23	2020-07-21	4	NGM	NGM BIOPHARMACEUTICALS INC Stock Option (Right to Buy)	M - Exercise	-24,000	0	-100.00
2020-07-23	2020-07-21	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	M - Exercise	24,000	44,000	120.00	13.35	320,400	587,400
2020-07-23	2020-05-20	4	NGM	NGM BIOPHARMACEUTICALS INC Stock Option (Right to Buy)	A - Award	16,806	16,806
2020-07-23	2019-05-15	4	NGM	NGM BIOPHARMACEUTICALS INC Stock Option (Right to Buy)	A - Award	24,000	24,000
2020-07-23	2019-05-15	4	NGM	NGM BIOPHARMACEUTICALS INC Stock Option (Right to Buy)	A - Award	24,000	24,000
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-07-23		3	NRIX	Nurix Therapeutics, Inc. Common Stock			166,666
2020-06-22	2020-06-18	4	RAPT	RAPT Therapeutics, Inc. Stock Option (Right to Buy)	J - Other	22,500	22,500
2020-06-19	2020-06-17	4	RVMD	Revolution Medicines, Inc. Stock Option (Right to Buy)	J - Other	25,318	25,318
2020-06-19	2020-06-17	4	RVMD	Revolution Medicines, Inc. Common Stock	J - Other	7,234	7,234
2020-06-19	2020-02-12	4	RVMD	Revolution Medicines, Inc. Stock Option (Right to Buy)	J - Other	36,168	36,168
2020-04-09	2020-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	112,602	1,540,071	7.89	14.95	1,683,400	23,024,061
2020-04-07	2020-04-07	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	123,728	1,427,469	9.49	14.38	1,779,209	20,527,004
2020-04-07	2020-04-03	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	14,587	1,303,741	1.13	12.41	181,025	16,179,426
2020-04-02	2020-04-02	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	14,850	1,289,154	1.17	12.40	184,140	15,985,510
2020-04-02	2020-04-01	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	118,067	1,274,304	10.21	12.26	1,447,501	15,622,967
2020-04-02	2020-03-31	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	118,067	1,156,237	11.37	12.53	1,479,380	14,487,650
2020-03-25	2020-03-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,416	1,038,170	0.23	12.49	30,176	12,966,743
2020-03-25	2020-03-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	128,377	1,035,754	14.15	12.22	1,568,767	12,656,914
2020-03-25	2020-03-23	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	170,387	907,377	23.12	11.63	1,981,601	10,552,795
2020-03-23	2020-03-20	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	143,082	736,990	24.09	11.77	1,684,075	8,674,372
2020-03-23	2020-03-19	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	148,464	593,908	33.33	11.59	1,720,698	6,883,394
2020-03-23	2020-03-20	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	P - Purchase	5,539	6,051,376	0.09	23.15	128,228	140,089,354
2020-03-23	2020-03-19	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	P - Purchase	36,135	6,045,837	0.60	22.38	808,701	135,305,832
2020-03-06	2020-03-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	8,307	445,444	1.90	18.00	149,526	8,017,992
2020-03-04	2020-03-04	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	9,986	437,137	2.34	17.96	179,349	7,850,981
2020-03-04	2020-03-03	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	38,758	427,151	9.98	17.99	697,256	7,684,446
2020-03-04	2020-03-02	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	14,124	388,393	3.77	17.90	252,820	6,952,235
2020-02-28	2020-02-28	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	37,800	374,269	11.23	17.91	676,998	6,703,158
2020-02-28	2020-02-27	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	33,896	336,469	11.20	17.91	607,077	6,026,160
2020-02-28	2020-02-26	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	3,751	302,573	1.26	18.00	67,518	5,446,314
2020-02-18	2020-02-18	4	RVMD	Revolution Medicines, Inc. Series C Preferred Stock	C - Conversion	-99,758	0	-100.00
2020-02-18	2020-02-18	4	RVMD	Revolution Medicines, Inc. Series B Preferred Stock	C - Conversion	-2,740,043	0	-100.00
2020-02-18	2020-02-18	4	RVMD	Revolution Medicines, Inc. Series A Preferred Stock	C - Conversion	-5,137,583	0	-100.00
2020-02-18	2020-02-18	4	RVMD	Revolution Medicines, Inc. Common Stock	C - Conversion	7,977,384	7,977,384
2020-02-10	2020-02-06	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	44,900	298,822	17.68	15.96	716,604	4,769,199
2019-11-13	2019-11-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	15	253,922	0.01	12.00	180	3,047,064
2019-11-06	2019-11-04	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	8,409	253,907	3.43	11.99	100,824	3,044,345
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Series C-2 Preferred Stock	C - Conversion	-872,410	0	-100.00
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Series C-2 Preferred Stock	C - Conversion	-872,410	0	-100.00
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Series C Preferred Stock	C - Conversion	-8,724,100	0	-100.00
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Series C Preferred Stock	C - Conversion	-4,362,050	0	-100.00
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Series B Preferred Stock	C - Conversion	-7,000,000	0	-100.00
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Series A Preferred Stock	C - Conversion	-14,781,963	0	-100.00
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	C - Conversion	145,401	145,401
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	C - Conversion	145,401	145,401
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	C - Conversion	1,454,016	1,454,016
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	P - Purchase	625,000	4,982,333	14.34	12.00	7,500,000	59,787,996
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	C - Conversion	727,008	4,357,333	20.03
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	C - Conversion	1,166,666	3,630,325	47.36
2019-11-04	2019-11-04	4	RAPT	RAPT Therapeutics, Inc. Common Stock	C - Conversion	2,463,659	2,463,659
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-30		3	RAPT	RAPT Therapeutics, Inc. Common Stock			100,000
2019-10-24	2019-10-23	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,087	245,498	0.86	11.86	24,752	2,911,606
2019-10-24	2019-10-22	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,300	243,411	0.95	12.00	27,600	2,920,932
2019-10-21	2019-10-21	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	43,400	241,111	21.95	11.94	518,196	2,878,865
2019-10-21	2019-10-18	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	34,721	197,711	21.30	11.29	392,000	2,232,157
2019-10-21	2019-10-17	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	6,818	162,990	4.37	10.62	72,407	1,730,954
2019-10-16	2019-10-16	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	34,900	156,172	28.78	10.26	358,074	1,602,325
2019-10-16	2019-10-15	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	33,200	121,272	37.70	10.31	342,292	1,250,314
2019-10-16	2019-10-14	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	34,900	88,072	65.64	10.36	361,564	912,426
2019-10-11	2019-10-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	17,724	53,172	50.00	10.57	187,343	562,028
2019-10-11	2019-10-10	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	17,724	35,448	100.00	10.50	186,102	372,204
2019-10-11	2019-10-09	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	17,724	17,724		10.26	181,848	181,848
2019-10-07	2019-10-03	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	P - Purchase	80,000	159,155	101.07	8.50	680,000	1,352,818
2019-10-07	2019-10-03	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	P - Purchase	1,331,764	6,009,702	28.47	8.50	11,319,994	51,082,467
2019-08-09	2019-08-09	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	152	2,597,816	0.01	13.99	2,126	36,343,446
2019-08-09	2019-08-08	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	12	2,597,664	0.00	13.98	168	36,315,343
2019-08-09	2019-08-07	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	224,500	2,597,652	9.46	14.00	3,143,000	36,367,128
2019-08-07	2019-08-06	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	310	2,373,152	0.01	13.96	4,328	33,129,202
2019-08-07	2019-08-05	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	5,824	2,372,842	0.25	13.98	81,400	33,164,263
2019-08-05	2019-08-02	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	1,782	2,367,018	0.08	13.97	24,898	33,072,212
2019-08-05	2019-08-01	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	2,600	2,365,236	0.11	13.98	36,346	33,064,107
2019-07-31	2019-07-30	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	8,855	2,362,636	0.38	13.91	123,195	32,870,173
2019-07-31	2019-07-29	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	19,201	2,353,781	0.82	13.58	260,727	31,961,521
2019-07-26	2019-07-26	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	30,059	2,334,580	1.30	13.59	408,634	31,737,214
2019-07-26	2019-07-25	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	30,753	2,304,521	1.35	13.37	411,294	30,820,894
2019-07-26	2019-07-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	29,054	2,273,768	1.29	13.51	392,502	30,717,241
2019-07-23	2019-07-23	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	30,760	2,244,714	1.39	13.35	410,535	29,958,851
2019-07-23	2019-07-22	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	30,760	2,213,954	1.41	13.54	416,337	29,965,867
2019-07-23	2019-07-19	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	6,222	2,183,194	0.29	13.99	87,043	30,541,792
2019-07-17	2019-07-16	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	3,900	2,176,972	0.18	13.86	54,055	30,173,485
2019-07-17	2019-07-15	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	16,188	2,173,072	0.75	13.69	221,547	29,740,446
2019-07-15	2019-07-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	21,014	2,156,884	0.98	13.88	291,765	29,946,825
2019-07-15	2019-07-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	10,870	2,135,870	0.51	13.87	150,752	29,621,527
2019-06-26	2019-06-24	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	12,240	2,125,000	0.58	13.78	168,650	29,279,525
2019-06-21	2019-06-21	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	3,763	2,112,760	0.18	14.03	52,789	29,638,854
2019-06-21	2019-06-20	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	15,400	2,108,997	0.74	13.86	213,385	29,222,684
2019-06-21	2019-06-19	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	15,214	2,093,597	0.73	13.91	211,674	29,128,424
2019-06-14	2019-06-14	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	10,760	2,078,383	0.52	14.00	150,687	29,106,507
2019-06-14	2019-06-13	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	11,500	2,067,623	0.56	14.13	162,508	29,217,787
2019-06-14	2019-06-12	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	7,500	2,056,123	0.37	14.00	104,989	28,782,638
2019-06-11	2019-06-11	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	10,900	2,048,623	0.53	13.83	150,718	28,326,925
2019-06-11	2019-06-07	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	12,600	2,037,723	0.62	13.66	172,176	27,845,077
2019-06-06	2019-06-06	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	12,600	2,025,123	0.63	13.40	168,884	27,143,736
2019-06-06	2019-06-04	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	12,600	2,012,523	0.63	13.39	168,764	26,955,733
2019-05-22	2019-05-20	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	50,000	1,999,923	2.56	13.50	675,000	26,998,960
2019-05-13	2019-05-10	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	17,923	1,949,923	0.93	13.85	248,234	27,006,434
2019-05-09	2019-05-07	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	57,000	1,932,000	3.04	14.10	803,700	27,241,200
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Series D Preferred Stock	C - Conversion	-3,400,000	0	-100.00
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Series C Preferred Stock	C - Conversion	-2,377,334	0	-100.00
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Series B Preferred Stock	C - Conversion	-8,408,933	0	-100.00
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Series A Preferred Stock	C - Conversion	-12,000,000	0	-100.00
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	15,000	15,000		16.00	240,000	240,000
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	P - Purchase	1,875,000	1,875,000		16.00	30,000,000	30,000,000
2019-04-10	2019-04-08	4	NGM	NGM BIOPHARMACEUTICALS INC Common Stock	C - Conversion	13,093,134	13,569,091	2,750.91
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			3,765,000
2019-04-09		3	NGM	NGM BIOPHARMACEUTICALS INC Common Stock			1,905,000
2019-04-02	2019-04-02	4	IMDZ	IMMUNE DESIGN CORP. Common Stock	U - Other	-6,642,942	0	-100.00	5.85	-38,861,211
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series F Preferred Stock	C - Conversion	-300,000	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series F Preferred Stock	C - Conversion	-20,000,000	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series E-1 Preferred Stock	C - Conversion	-6,502,856	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series E Preferred Stock	C - Conversion	-444,444	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series E Preferred Stock	C - Conversion	-3,555,555	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series D Preferred Stock	C - Conversion	-970,159	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion	-8,333,333	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Series A Preferred Stock	C - Conversion	-11,000,000	0	-100.00
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	C - Conversion	79,155	79,155
2018-07-23	2018-07-23	4	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock	C - Conversion	4,666,888	4,677,939	42,230.46
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-07-18		3	CNST	CONSTELLATION PHARMACEUTICALS INC Common Stock			22,102
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Series C Preferred Stock	C - Conversion	-470,427	0	-100.00
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Series C Preferred Stock	C - Conversion	-427,660	0	-100.00
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Series B Preferred Stock	C - Conversion	-875,087	0	-100.00
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Series A Preferred Stock	C - Conversion	-1,767,676	0	-100.00
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Common Stock	C - Conversion	470,427	470,427
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Common Stock	C - Conversion	427,660	3,070,423	16.18
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Common Stock	C - Conversion	875,087	2,642,763	49.50
2018-03-19	2018-03-19	4	RCUS	Arcus Biosciences, Inc. Common Stock	C - Conversion	1,767,676	1,767,676
2017-10-30	2017-10-27	4	IMDZ	Immune Design Corp. Common Stock	P - Purchase	2,681,000	6,642,942	67.67	4.10	10,992,100	27,236,062
2017-10-30		3	IMDZ	Immune Design Corp. Common Stock			5,362,000
2017-10-30		3	IMDZ	Immune Design Corp. Common Stock			5,362,000
2017-10-30		3	IMDZ	Immune Design Corp. Common Stock			5,362,000
2017-10-30		3	IMDZ	Immune Design Corp. Common Stock			5,362,000

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)